SRPT 8-K 2026-09-23

Sarepta Therapeutics, Inc. (SRPT) 8-K dated 2026-09-23 — accession 0001193125-26-399416. This URL is the filing, not the SRPT hub.

Sarepta Therapeutics, Inc. (SRPT) is a biotechnology company listed on US.

Sarepta Therapeutics, Inc. filed a 8-K on 2026-09-23. Accession 0001193125-26-399416.

Cached items: 1.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported SRPT revenue for 2026-06-30 was $401.3M. Net income was -$4.9M. Revenue was down 45.1% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.

Not investment advice. The SRPT SEC hub lists recent forms. The stock page is the research view.